It is suggested that CMTM6 can regulate the activity of Wnt/β-catenin signaling pathway and affect the progression of EMT and the maintenance of cancer stem cells (CSCs) as well as immune response, making it a potential target for HNSCC treatment. Here, CMTM6 is linked to cancer.